ResearchGate See discussions, stats, and author profiles for this publication at: https:lJwww.researchgate.net/publication/26648260 Lumbar spinal stenosis: Synd

From: Boris Nikolic To: "Jeffrey Epstein ([email protected])" <[email protected]> Subject: Nature article on ResearchGate! Date: Sat, 16 Aug 2014 16:09:26 +0000 ResearchGate is getting there! This week, the Nature (one of the competitors) published this article — esse

uch investment, together with any and all dividends, payments, distributions, securities or other items of value at any time distributed or paid by ResearchGate to the Gates Purchaser in respect of such investment shall be referred to herein as the "ResearchGate Investment"). At any time and from time to t

uch investment, together with any and all dividends, payments, distributions, securities or other items of value at any time distributed or paid by ResearchGate to the Gates Purchaser in respect of such investment shall be referred to herein as the "ResearchGate Investment"). At any time and from time to t

, Lilly Ventures and Schrodinger (9.5%). Research Gate ResearchCate is developing a social networking site for the research scientist community. At ResearchGate. more than 3.5 million researchers already share and curate their data and results. The site has been described as a mashup of -Facebook, Twitter a

request to purchase from [bgC3] (a) up to 30% of [bgC3]'s equity interests in Foundation Medicine and (b) up to 30% of [bgC3]'s equity interests in ResearchGate, in each case in cash at a price per share or unit equivalent to the original price per share or unit paid by [bgC3] (collectively, the "Investment

ResearchGate See discussions, stats.and author ;ogees let Ilics oubleation as: Mimi/Mem researchgale on/publicalem/20362017 Field Test of the Cognitive Intervie

g 16, 2014 at 12:54 PM, Boris =ikolic < > wrote: Not sure that it is worth=doing it. Not sure re tax implicati=ns. And I can't do it=right now as ResearchGate still did not start fundrising (they are working=on a major strategic move which might even more inflate the valuation).=/u> If I will face a probl

g 16, 2014 at 12:54 PM, Boris Nikolic > wrote: Not sure that it is worth doing it. Not sure re tax implications. And I can't do it right now as ResearchGate still did not start fundrising (they are working on a major strategic move which might even more inflate the valuation). If I will face a problem w

2014 4:55 PM To: Jeffrey E. Subject: RE: copy Not sure that it is worth doing it. Not sure re tax implications. And I can't do it right now as ResearchGate still did not start fundrising (they are working on a major strategic move which might even more inflate the valuation). If I will face a problem w

Aug 16, 2014 at 12:54 =M, Boris Nikolic > wrote: Not sure that it is worth=doing it. Not sure re tax implicati=ns. And I can't do it=right now as ResearchGate still did not start fundrising (they are working=on a major strategic move which might even more inflate the valuation).=/u> If I will face a probl

t (including all dividends, payments, distributions, securities and other items of value at any time previously or hereafter distributed or paid by ResearchGate in - 63 - EFTA_R1_00438149 EFTA01961337 3. respect of such investment) as of the date of such Investment Entity Payment Demand, less (b) Ten Mi